These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35259441)

  • 1. Modification of small dissolution chamber system for long-acting periodontal drug product evaluation.
    Wanasathop A; Murawsky M; Li SK
    Int J Pharm; 2022 Apr; 618():121646. PubMed ID: 35259441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissolution Chamber for Small Drug Delivery System in the Periodontal Pocket.
    Ren W; Murawsky M; La Count T; Wanasathop A; Hao X; Kelm GR; Kozak D; Qin B; Li SK
    AAPS J; 2019 Apr; 21(3):51. PubMed ID: 30972562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biorelevant and screening dissolution methods for minocycline hydrochloride microspheres intended for periodontal administration.
    Patel SK; Greene AC; Desai SM; Rothstein S; Basha IT; MacPherson JS; Wang Y; Zou Y; Shehabeldin M; Sfeir CS; Little SR; Rohan LC
    Int J Pharm; 2021 Mar; 596():120261. PubMed ID: 33486044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local antimicrobial therapy after initial periodontal treatment.
    Salvi GE; Mombelli A; Mayfield L; Rutar A; Suvan J; Garrett S; Lang NP
    J Clin Periodontol; 2002 Jun; 29(6):540-50. PubMed ID: 12296782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of the in vivo performance of enteric coated pellets in the fasted state under selected biorelevant dissolution conditions.
    Stefanič M; Vrečer F; Rizmal P; Mrhar A; Bogataj M
    Eur J Pharm Sci; 2014 Oct; 62():8-15. PubMed ID: 24844699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Subgingival Mechanical Debridement and Local Delivery of Chlorhexidine Gluconate Chip or Minocycline Hydrochloride Microspheres in Patients Enrolled in Supportive Periodontal Therapy: a Retrospective Analysis.
    Chackartchi T; Hamzani Y; Shapira L; Polak D
    Oral Health Prev Dent; 2019; 17(2):167-171. PubMed ID: 30968072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
    Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous Evaluation of Dissolution and Permeation of Oral Drug Solid Formulations for Predicting Absorption Rate-Limiting Factors and In Vitro-In Vivo Correlations: Case Study Using a Poorly Soluble Weakly Basic Drug.
    Li Z; He X; Tian S; Feng G; Huang C; Xun M; Wu Z; Wang Y
    AAPS PharmSciTech; 2019 Oct; 20(8):321. PubMed ID: 31650430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro biorelevant models for evaluating modified release mesalamine products to forecast the effect of formulation and meal intake on drug release.
    Andreas CJ; Chen YC; Markopoulos C; Reppas C; Dressman J
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):39-50. PubMed ID: 26391972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory perspectives on in vitro (dissolution)/in vivo (bioavailability) correlations.
    Uppoor VR
    J Control Release; 2001 May; 72(1-3):127-32. PubMed ID: 11389991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulation of in vitro dissolution behavior using DDDPlus™.
    Almukainzi M; Okumu A; Wei H; Löbenberg R
    AAPS PharmSciTech; 2015 Feb; 16(1):217-21. PubMed ID: 25409918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simulating Different Dosing Scenarios for a Child-Appropriate Valproate ER Formulation in a New Pediatric Two-Stage Dissolution Model.
    Karkossa F; Krueger A; Urbaniak J; Klein S
    AAPS PharmSciTech; 2017 Feb; 18(2):309-316. PubMed ID: 27909943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of Bioequivalent Extended-Release Formulations for Metformin by Principal Component Analysis and Convolution-Based IVIVC Approach.
    Zhang Y; Liu H; Tang MJ; Ho NJ; Shek TL; Yang Z; Zuo Z
    AAPS J; 2021 Mar; 23(2):38. PubMed ID: 33665728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of PBPK Modeling To Evaluate the Performance of Dissolv It, a Biorelevant Dissolution Assay for Orally Inhaled Drug Products.
    Hassoun M; Malmlöf M; Scheibelhofer O; Kumar A; Bansal S; Selg E; Nowenwik M; Gerde P; Radivojev S; Paudel A; Arora S; Forbes B
    Mol Pharm; 2019 Mar; 16(3):1245-1254. PubMed ID: 30640475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of in vivo drug performance using in vitro dissolution coupled with STELLA: a study with selected drug products.
    Chakraborty S; Yadav L; Aggarwal D
    Drug Dev Ind Pharm; 2015; 41(10):1667-73. PubMed ID: 25494535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward Biopredictive Dissolution for Enteric Coated Dosage Forms.
    Al-Gousous J; Amidon GL; Langguth P
    Mol Pharm; 2016 Jun; 13(6):1927-36. PubMed ID: 27139040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory response to chlorhexidine, minocycline HCl and doxycycline HCl in an in vivo mouse model.
    Houri-Haddad Y; Halabi A; Soskolne WA
    J Clin Periodontol; 2008 Sep; 35(9):783-8. PubMed ID: 18651847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Dissolution Method for Oral Film Preparations with Modified Release Properties.
    Speer I; Preis M; Breitkreutz J
    AAPS PharmSciTech; 2018 Dec; 20(1):7. PubMed ID: 30560468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can dosage form-dependent food effects be predicted using biorelevant dissolution tests? Case example extended release nifedipine.
    Andreas CJ; Tomaszewska I; Muenster U; van der Mey D; Mueck W; Dressman JB
    Eur J Pharm Biopharm; 2016 Aug; 105():193-202. PubMed ID: 27322002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.